{"id":63303,"date":"2021-05-18T16:11:05","date_gmt":"2021-05-18T14:11:05","guid":{"rendered":"https:\/\/www.pcb.ub.edu\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/"},"modified":"2021-05-19T08:52:33","modified_gmt":"2021-05-19T07:52:33","slug":"aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/","title":{"rendered":"Aelix Therapeutics announces the appointment of Dr Melanie Rolli as a new CEO"},"content":{"rendered":"<p><strong>The clinical-stage biotechnology company <a href=\"https:\/\/www.pcb.ub.edu\/en\/empresa\/aelix-therapeutics\/\" target=\"_blank\" rel=\"noopener\">Aelix Therapeutics<\/a> -based in the Barcelona Science Park and specialized in the discovery and development of immunotherapies for HIV infection- today announces the appointment of Dr Melanie Rolli as chief executive officer, following the decision of her predecessor, Dr Jos\u00e9 Luis Cabero, to step down from executive positions at Aelix.<\/strong><\/p>\n<p><strong>Dr Melani Rolli<\/strong> brings a wealth of knowledge to her new role as a CEO, with decades of hands-on experience in the pharmaceutical sector, including various positions of increasing responsibility whilst at Novartis.<\/p>\n<p>\u201cI\u2019m excited to join a high-performing team that has achieved a major milestone by translating a biological concept into positive clinical results with their first clinical trial. Our goal now is to advance the program and bring an innovative HIV functional cure therapy to patients\u201d, states Dr Rolli.<\/p>\n<p>This appointment follows the company\u2019s March 2021 announcement of positive topline results in the\u00a0<a href=\"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-announces-positive-topline-results-positive-results-from-the-phase-i-iia-therapeutic-hiv-vaccine-clinical-trial\/\" target=\"_blank\" rel=\"noopener\">AELIX-002 Phase I\/II clinical trial<\/a>. The strong data represent a major breakthrough development in the field and the results support Aelix\u2019s plans for larger combination trials.<\/p>\n<p>\u201cWe are delighted to welcome Dr Melanie Rolli to the team. Her invaluable experience and key skills will further support our ambitions, steer our growth and direct our development programs. We look forward to the next chapter under Melanie\u2019s leadership,\u201d says <strong>Dr Thomas Hecht<\/strong>, chairman of Aelix\u2019 board of directors. \u201cWe also want to express a big thank you to<strong> Jos\u00e9 Luis Cabero<\/strong> for steering the ship over the last few years,\u201d Dr Hecht added.<\/p>\n<p>The appointment of Dr Rolli will support Aelix\u2019s vision of positioning HTI vaccines for future cure strategies and becoming the front-runner in HIV treatment by bringing a therapeutic vaccine to the market.<\/p>\n<p>The positive results from the clinical trial support further development of combination strategies based on the HTI vaccine, with the aim of controlling HIV without the need for continued antiretroviral medication. Aelix plans to rapidly conduct multiple clinical trials including the ongoing collaboration phase II study with Gilead Sciences that combines the HTI vaccine with the TLR-7 agonist Vesatolimod.<\/p>\n<p><strong>\u00bb More information: <a href=\"https:\/\/www.aelixtherapeutics.com\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo-2\/\" target=\"_blank\" rel=\"noopener\">Aelix Therapeutics website [+]<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The clinical-stage biotechnology company Aelix Therapeutics -based in the Barcelona Science Park and specialized in the discovery and development of immunotherapies for HIV infection- today announces the appointment of Dr&#8230;<\/p>\n","protected":false},"author":14,"featured_media":63297,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[35],"tags":[],"class_list":["post-63303","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aelix Therapeutics announces the appointment of Dr Melanie Rolli as a new CEO - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aelix Therapeutics announces the appointment of Dr Melanie Rolli as a new CEO - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"The clinical-stage biotechnology company Aelix Therapeutics -based in the Barcelona Science Park and specialized in the discovery and development of immunotherapies for HIV infection- today announces the appointment of Dr...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-18T14:11:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-19T07:52:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Melanie-Rolli-web.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"586\" \/>\n\t<meta property=\"og:image:height\" content=\"330\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Paula Ca\u00f1al\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paula Ca\u00f1al\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\\\/\"},\"author\":{\"name\":\"Paula Ca\u00f1al\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"headline\":\"Aelix Therapeutics announces the appointment of Dr Melanie Rolli as a new CEO\",\"datePublished\":\"2021-05-18T14:11:05+00:00\",\"dateModified\":\"2021-05-19T07:52:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\\\/\"},\"wordCount\":364,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/Melanie-Rolli-web.jpg\",\"articleSection\":[\"COMPANIES\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\\\/\",\"name\":\"Aelix Therapeutics announces the appointment of Dr Melanie Rolli as a new CEO - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/Melanie-Rolli-web.jpg\",\"datePublished\":\"2021-05-18T14:11:05+00:00\",\"dateModified\":\"2021-05-19T07:52:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/Melanie-Rolli-web.jpg\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/Melanie-Rolli-web.jpg\",\"width\":586,\"height\":330},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aelix Therapeutics announces the appointment of Dr Melanie Rolli as a new CEO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\",\"name\":\"Paula Ca\u00f1al\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"caption\":\"Paula Ca\u00f1al\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/author\\\/paula\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aelix Therapeutics announces the appointment of Dr Melanie Rolli as a new CEO - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/","og_locale":"en_US","og_type":"article","og_title":"Aelix Therapeutics announces the appointment of Dr Melanie Rolli as a new CEO - Parc Cient\u00edfic de Barcelona","og_description":"The clinical-stage biotechnology company Aelix Therapeutics -based in the Barcelona Science Park and specialized in the discovery and development of immunotherapies for HIV infection- today announces the appointment of Dr...","og_url":"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2021-05-18T14:11:05+00:00","article_modified_time":"2021-05-19T07:52:33+00:00","og_image":[{"width":586,"height":330,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Melanie-Rolli-web.jpg","type":"image\/jpeg"}],"author":"Paula Ca\u00f1al","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Paula Ca\u00f1al","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/"},"author":{"name":"Paula Ca\u00f1al","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"headline":"Aelix Therapeutics announces the appointment of Dr Melanie Rolli as a new CEO","datePublished":"2021-05-18T14:11:05+00:00","dateModified":"2021-05-19T07:52:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/"},"wordCount":364,"image":{"@id":"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Melanie-Rolli-web.jpg","articleSection":["COMPANIES"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/","url":"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/","name":"Aelix Therapeutics announces the appointment of Dr Melanie Rolli as a new CEO - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Melanie-Rolli-web.jpg","datePublished":"2021-05-18T14:11:05+00:00","dateModified":"2021-05-19T07:52:33+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Melanie-Rolli-web.jpg","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Melanie-Rolli-web.jpg","width":586,"height":330},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/en\/aelix-therapeutics-appoints-dr-melanie-rolli-as-ceo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/en\/"},{"@type":"ListItem","position":2,"name":"Aelix Therapeutics announces the appointment of Dr Melanie Rolli as a new CEO"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a","name":"Paula Ca\u00f1al","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","caption":"Paula Ca\u00f1al"},"url":"https:\/\/www.pcb.ub.edu\/en\/author\/paula\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts\/63303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/comments?post=63303"}],"version-history":[{"count":8,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts\/63303\/revisions"}],"predecessor-version":[{"id":63345,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts\/63303\/revisions\/63345"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/media\/63297"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/media?parent=63303"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/categories?post=63303"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/tags?post=63303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}